Public Employees Retirement System of Ohio decreased its position in Stryker Corporation (NYSE:SYK) by 3.1% during the first quarter, Holdings Channel reports. The institutional investor owned 231,745 shares of the medical technology company’s stock after selling 7,511 shares during the period. Public Employees Retirement System of Ohio’s holdings in Stryker Corporation were worth $30,509,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the company. Bollard Group LLC boosted its stake in shares of Stryker Corporation by 0.4% in the first quarter. Bollard Group LLC now owns 829 shares of the medical technology company’s stock valued at $109,000 after buying an additional 3 shares in the last quarter. Baystate Wealth Management LLC boosted its stake in shares of Stryker Corporation by 2.1% in the first quarter. Baystate Wealth Management LLC now owns 1,066 shares of the medical technology company’s stock valued at $139,000 after buying an additional 22 shares in the last quarter. Guardian Life Insurance Co. of America boosted its stake in shares of Stryker Corporation by 0.8% in the first quarter. Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company’s stock valued at $158,000 after buying an additional 9 shares in the last quarter. Assetmark Inc. boosted its stake in shares of Stryker Corporation by 0.3% in the first quarter. Assetmark Inc. now owns 1,274 shares of the medical technology company’s stock valued at $168,000 after buying an additional 4 shares in the last quarter. Finally, Daiwa SB Investments Ltd. acquired a new stake in shares of Stryker Corporation during the first quarter valued at about $170,000. 73.99% of the stock is owned by institutional investors and hedge funds.

Shares of Stryker Corporation (NYSE SYK) traded up 0.19% during trading on Friday, hitting $144.18. 847,631 shares of the stock traded hands. Stryker Corporation has a 52-week low of $106.48 and a 52-week high of $148.84. The company’s 50 day moving average is $143.71 and its 200 day moving average is $135.51. The firm has a market cap of $53.93 billion, a PE ratio of 32.18 and a beta of 0.80.

Stryker Corporation (NYSE:SYK) last released its earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.51 by $0.02. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The firm had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.98 billion. During the same period in the previous year, the firm earned $1.39 earnings per share. Stryker Corporation’s revenue was up 6.1% compared to the same quarter last year. On average, equities research analysts predict that Stryker Corporation will post $6.50 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be issued a $0.425 dividend. The ex-dividend date is Thursday, September 28th. This represents a $1.70 dividend on an annualized basis and a yield of 1.18%. Stryker Corporation’s payout ratio is 37.95%.

TRADEMARK VIOLATION WARNING: “Public Employees Retirement System of Ohio Reduces Stake in Stryker Corporation (SYK)” was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright legislation. The legal version of this piece of content can be read at https://www.watchlistnews.com/public-employees-retirement-system-of-ohio-reduces-stake-in-stryker-corporation-syk/1479401.html.

Several analysts recently issued reports on the stock. BidaskClub cut shares of Stryker Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Jefferies Group LLC reaffirmed a “hold” rating and set a $132.00 price objective on shares of Stryker Corporation in a research note on Friday, June 30th. Barclays PLC reaffirmed a “sell” rating and set a $133.00 price objective on shares of Stryker Corporation in a research note on Thursday, April 27th. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $148.00 price objective on shares of Stryker Corporation in a research note on Monday, April 17th. Finally, Oppenheimer Holdings, Inc. set a $148.00 price objective on shares of Stryker Corporation and gave the company a “hold” rating in a research note on Friday, July 28th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and twelve have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $144.03.

In other Stryker Corporation news, insider Graham A. Mclean sold 1,124 shares of Stryker Corporation stock in a transaction that occurred on Tuesday, August 8th. The shares were sold at an average price of $146.26, for a total transaction of $164,396.24. Following the transaction, the insider now directly owns 8,983 shares of the company’s stock, valued at $1,313,853.58. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Lonny J. Carpenter sold 5,000 shares of Stryker Corporation stock in a transaction that occurred on Friday, August 4th. The shares were sold at an average price of $146.36, for a total transaction of $731,800.00. Following the transaction, the insider now directly owns 88,207 shares in the company, valued at $12,909,976.52. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 32,810 shares of company stock valued at $4,754,958. 7.40% of the stock is owned by insiders.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.